BioSpace News Archive

Bionoid Pharma, Inc. announced today that it has signed a Letter of Intent to acquire all the outstanding shares of Global Alerts Corp.

Syneos Health today announced a strategic partnership with KX, maker of kdb, the world’s fastest time series database and analytics engine.

Yesterday, Vectorious Medical Technologies Ltd. presented interim results from its Left Atrial Pressure (LAP) Guided, Patient Self-Management (PSM) pilot study during a featured abstract session at THT 2023 in Boston.

Annovis Bio, Inc. today announced the Company will be making two presentations at the upcoming AD/PD ™ 2023 International Conference on Alzheimer’s and Parkinson’s Disease, which is taking place from March 28 through April 1, 2023, in Gothenburg, Sweden.

Capstan Therapeutics, Inc. today announced the appointment of Justin Thacker as Chief Financial Officer and Jeffrey Pepe, J.D., Ph.D. as General Counsel.

VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that David Domzalski, President and Chief Executive Officer, and Dr. Iain Stuart, Chief Scientific Officer, will participate in a fireside chat at the H.C. Wainwright Autoimmune & Inflammation Disease Virtual Conference being held on Thursday, March 30, 2023.

Galderma announced today the launch of FACE by Galderma™, an innovative aesthetic visualization tool powered by augmented reality (AR) that allows aesthetic professionals and patients to visualize injectable treatment results* at the planning stage before treatment begins.

Caraway Therapeutics today announced that the Company will be participating in the Stifel CNS Days event on March 29, 2023.

Cognito Therapeutics announced today a $73M Series B financing round led by FoundersX Ventures with participation from all existing investors.

POXEL SA announced that it will report its 2022 full year results by the end of March 2023.